Mirabegron Extended Release 50mg tablet contains Mirabegron, a selective beta-3 adrenergic receptor agonist used for the management of overactive bladder (OAB). It works by relaxing the detrusor smooth muscle of the urinary bladder during the storage phase of the urinary bladder fill-void cycle, thereby increasing bladder capacity. This extended-release formulation ensures gradual drug release over 24 hours, providing sustained symptom control with once-daily dosing. It helps reduce urinary urgency, frequency, and urge incontinence episodes, improving patient comfort and quality of life. Mirabegron is often preferred in patients who cannot tolerate anticholinergic medications due to side effects like dry mouth or constipation.
